Jul. 17 at 5:03 PM
$FOCL Chief Financial Officer Ken Mobeck said the FOCL is at an “important inflection point,” with HIFU expected to represent more than 60% of company revenue in 2026 based on guidance. Mobeck said the company recently announced its intent to classify non-core businesses as discontinued operations and is maintaining HIFU revenue guidance of
$50 million to
$54 million for the year.
Mobeck said the company is targeting approximately 40% annual revenue growth, gross margins of 60%, operating income break-even by the end of 2028 and positive EBITDA during 2028. He said growth drivers include continued system placements, procedure volumes, international expansion and future contributions from new indications.
